Ibraheem Othman

Ibraheem Othman

Saskatchewan Cancer Agency - Saskatoon / Canada
Medical and Health Sciences / Internal Medicine
AD Scientific Index ID: 4789501
-
person_outline Ibraheem Othman's MOST POPULAR ARTICLES
1-) The International/Canadian hereditary angioedema guideline S Betschel, J Badiou, K Binkley, R Borici-Mazi, J Hébert, A Kanani, ... Allergy, Asthma & Clinical Immunology 15 (1), 1-29, 2019 1252019
2-) Part 1 results of a dose-finding study of belantamab mafodotin in combination with pomalidomide and dexamethasone for the treatment of relapsed/refractory multiple myeloma (RRMM) S Trudel, A McCurdy, HJ Sutherland, ML Louzada, CP Venner, HS Mian, ... Blood 138, 1653, 2021 102021
3-) Management of myeloma manifestations and complications: the cornerstone of supportive care: recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada …R LeBlanc, DJ Bergstrom, J Côté, R Kotb, ML Louzada, HJ SutherlandClinical Lymphoma Myeloma and Leukemia 22 (1), e41-e56, 2022152022
4-) Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trialS Trudel, A McCurdy, ML Louzada, S Parkin, D White, MP Chu, R Kotb, ...Nature Medicine 30 (2), 543-551, 2024142024
5-) Belantamab mafodotin in combination with pomalidomide and dexamethasone demonstrates durable responses in triple class exposed/refractory multiple myelomaS Trudel, A McCurdy, M Fu, HJ Sutherland, ML Louzada, MP Chu, ...Blood 140 (Supplement 1), 7306-7307, 2022142022